An in-depth critical analysis of Morgellons: Delusion or disease?

Abstract

Morgellons is a poorly understood entity and is characterized by cutaneous findings such as fibers emerging from the skin, which can cause secondary symptoms such as formication and itching. Morgellons is an understudied area with conflicting results; this imposes challenges to clinicians while navigating consultations and understanding, diagnosing, and treating Morgellons. This literature review summarizes the available data on the etiology, epidemiology, clinical presentation, treatment, and social media influence within Morgellons. Medical Subject Headings terms were used to systematically search PubMed, Medline, and EMBASE, and two independent reviewers screened the selected articles, revealing that Morgellons is poorly understood among the scientific community, with a population prevalence of 3.65/100,000. The etiology of Morgellons is controversial, and opinions among psychiatrists and dermatologists are conflicting. Some studies propose a biological origin linked to Lyme disease, whereas others view Morgellons as a delusional disorder without an underlying pathology. The conflicting views can be attributed to the lack of robust research with no consensus on an established pathophysiology, disease classification, or treatment guidelines. Herein, the majority of literature views Morgellons as a delusional disorder, wherein an underlying pathology triggers the delusional experience. However, further studies are required to accurately classify the disease and direct patients to the right specialists to ensure effective treatment and development of treatment guidelines. Nevertheless, a holistic treatment approach, integrating psychosomatic and dermatological modalities, is lacking.

Keywords

Morgellons disease / Delusional infestation / Delusional disorder

Funding

None.

Conflict of interest

The authors declare they have no competing interests.

References

[1] Pearson ML, Selby JV, Katz KA, et al. Clinical, epidemiologic, histopathologic and molecular features of an unexplained dermopathy. PLoS One. 2012; 7(1):e29908. doi: 10.1371/journal.pone.0029908

[2] Mohandas P, Bewley A, Taylor R. Morgellons disease: Experiences of an integrated multidisciplinary dermatology team to achieve positive outcomes. J Dermatolog Treat. 2018; 29(2):208-213. doi: 10.1080/09546634.2017.1349868

[3] Alfaris S, France K, Sollecito TP, Stoopler ET. Treatment of oral mucosal lesions associated with overlapping psychodermatologic disorders. Compend Contin Educ Dent. 2018; 39(4):244-1246.

[4] Ranka N, Godse K, Nadkarni N, Patil S, Agarwal S. Morgellons disease: A myth or reality? Indian Dermatol Online J. 2016; 7(5):430-432. doi: 10.4103/2229-5178.190500

[5] Kellett CE. Sir Thomas Browne and the disease called the morgellons. Ann Med Hist. 1935; 7(5):467-479.

[6] Chu C. Morgellons disease-dredged up from history and customized. JAMA Dermatol. 2018; 154(4):451. doi: 10.1001/jamadermatol.2017.6393

[7] Norman FF, López-Vélez R. Delusional parasitosis: An unrecognized and underdiagnosed entity? Enferm Infecc Microbiol Clin (Engl Ed). 2021; 39(5):221-222. doi: 10.1016/j.eimc.2021.03.001

[8] Nunziato CA, Egeland BM, Gurman A, Henry SL. Morgellons disease: The spread of a mass psychogenic illness via the internet and its implications in hand surgery. Hand (N Y). 2021; 16(6):NP5-NP9. doi: 10.1177/1558944720976648

[9] Orsolini L, Gentilotti A, Giordani M, Volpe U. Historical and clinical considerations on Ekbom’s syndrome. Int Rev Psychiatry. 2020; 32(5-6):424-436. doi: 10.1080/09540261.2020.1757306

[10] Chan S, Xiao A, Patel S, Nakamura M, Koo J. Is Morgellons an organic disease? structural and functional abnormalities implicated in the pathophysiology of delusional infestation. Dermatol Online J. 2020; 26(11):13030/qt9n75c1wg.

[11] Tohid H, Shenefelt PD, Burney WA, Aqeel N. Psychodermatology: An association of primary psychiatric disorders with skin. Rev Colomb Psiquiatr (Engl Ed). 2019; 48(1):50-57. doi: 10.1016/j.rcp.2017.07.002

[12] Krooks JA, Weatherall AG, Holland PJ. Review of epidemiology, clinical presentation, diagnosis, and treatment of common primary psychiatric causes of cutaneous disease. J Dermatolog Treat. 2018; 29(4):418-427. doi: 10.1080/09546634.2017.1395389

[13] Substance Abuse and Mental Health Services Administration (US). Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration (US). Available from: . https://www.ncbi.nlm.nih.gov/books/NBK519704/table/ch3.t20.

[14] Wadmann S. Disease classification: A framework for analysis of contemporary developments in precision medicine. SSM - Qual Res Health. 2023;3:100217. doi: 10.1016/j.ssmqr.2023.100217

[15] Hylwa SA, Ronkainen SD. Delusional infestation versus Morgellons disease. Clin Dermatol. 2018; 36(6):714-718. doi: 10.1016/j.clindermatol.2018.08.007

[16] Harvey WT, Bransfield RC, Mercer DE, Wright AJ, Ricchi RM, Leitao MM. Morgellons disease, illuminating an undefined illness: A case series. J Med Case Rep. 2009;3:8243. doi: 10.4076/1752-1947-3-8243

[17] Dib El Jalbout J, Sati H, Ghalloub P, et al. Morgellons disease: A narrative review. Neurol Sci. 2024; 45(6):2579-2591. doi: 10.1007/s10072-024-07361-7

[18] Middelveen MJ, Martinez RM, Fesler MC, et al. Classification and staging of morgellons disease: Lessons from syphilis. Clin Cosmet Investig Dermatol. 2020; 13:145-164. doi: 10.2147/ccid.S239840

[19] Lai J, Xu Z, Xu Y, Hu S. Reframing delusional infestation: Perspectives on unresolved puzzles. Psychol Res Behav Manag. 2018; 11:425-432. doi: 10.2147/prbm.S166720

[20] DermNet. Morgellons Disease. DermNet NZ. 2024 Nov 21].

[21] Bailey CH, Andersen LK, Lowe GC, Pittelkow MR, Bostwick JM, Davis MD.A population-based study of the incidence of delusional infestation in Olmsted County, Minnesota, 1976-2010. Br J Dermatol. 2014; 170(5):1130-1135. doi: 10.1111/bjd.12848

[22] Freudenmann RW, Lepping P. Delusional infestation. Clin Microbiol Rev. 2009; 22(4):690-732. doi: 10.1128/cmr.00018-09

[23] Centre for Evidence-based Medicine. OCEBM Levels of Evidence. Centre for Evidence-based Medicine; 2024. Available from:. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence [Last accessed 2024 Nov 21].

[24] Miller K. WebMD. Available from: https://www. webmd.com/skin-problems-and-treatments/morgellons-disease-what-is-it#091e9c5e80b7e6ed-1-2 [Last accessed 2024 Nov 21].

[25] Middelveen MJ, Fesler MC, Stricker RB. History of Morgellons disease: From delusion to definition. Clin Cosmet Investig Dermatol. 2018; 11:71-90. doi: 10.2147/ccid.S152343

[26] Middelveen MJ, Stricker RB. Morgellons disease: A filamentous borrelial dermatitis. Int J Gen Med. 2016; 9:349-354. doi: 10.2147/ijgm.S116608

[27] Middelveen MJ, Bandoski C, Burke J, et al. Exploring the association between Morgellons disease and Lyme disease: Identification of Borrelia burgdorferi in Morgellons disease patients. BMC Dermatol. 2015; 15(1):1. doi: 10.1186/s12895-015-0023-0

[28] Middelveen M, Burugu D, Poruri A, et al. Association of spirochetal infection with Morgellons disease. F1000Res. 2013;2:25. doi: 10.12688/f1000research.2-25.v1

[29] Middelveen MJ, Cruz ID, Fesler MC, Stricker RB, Shah JS. Detection of tick-borne infection in Morgellons disease patients by serological and molecular techniques. Clin Cosmet Investig Dermatol. 2018; 11:561-569. doi: 10.2147/ccid.S184521

[30] Middelveen MJ, Filush KR, Bandoski C, et al. Mixed Borrelia burgdorferi and Helicobacter pylori Biofilms in Morgellons disease dermatological specimens. Healthcare (Basel). 2019; 7(2):70. doi: 10.3390/healthcare7020070

[31] Fesler MC, Middelveen MJ, Stricker RB. Clinical evaluation of Morgellons disease in a cohort of North American patients. Dermatol Reports. 2018; 10(1):7660. doi: 10.4081/dr.2018.7660

[32] Zhang JF, Gopalakrishnan K, Molloy DJ. Treatment of Morgellons disease with doxycycline. Clin Case Rep. 2021; 9(12):e05148. doi: 10.1002/ccr3.5148

[33] Kemperman P, Vulink NCC, Smit C, Hovius JW, de Rie MA. Review of literature and clinical practice experience for the therapeutic management of Morgellons disease. J Eur Acad Dermatol Venereol. 2024; 38(7):1300-1304. doi: 10.1111/jdv.19831

[34] Reich A, Kwiatkowska D, Pacan P. Delusions of parasitosis: An update. Dermatol Ther (Heidelb). 2019; 9(4):631-638. doi: 10.1007/s13555-019-00324-3

[35] Cohen PR. “Doctor, you must examine my creature collection!”: A case report of delusional infestation. Cureus. 2022; 14(6):e25758. doi: 10.7759/cureus.25758

[36] Middelveen MJ, Stricker RB. Filament formation associated with spirochetal infection: A comparative approach to Morgellons disease. Clin Cosmet Investig Dermatol. 2011; 4:167-177. doi: 10.2147/ccid.S26183

[37] Robles DT OJ, Combs H, Romm S, Kirby P. Morgellons disease and delusions of parasitosis. Am J Clin Dermatol. 2011;12:1-6. doi: 10.2165/11533150-000000000-00000

[38] Cutlip HA, Mogallapu R, Ang-Rabanes M. Morgellons disease treated as a psychosomatic condition. Cureus. 2022; 14(5):e25236. doi: 10.7759/cureus.25236

[39] Middelveen M, Rasmussen EH, Kahn DG, Stricker R. Morgellons disease: A chemical and light microscopic study. J Clin Exp Dermatol Res. 2012;3:1000140. doi: 10.4172/2155-9554.1000140

[40] Middelveen MJ, Mayne PJ, Kahn DG, Stricker RB. Characterization and evolution of dermal filaments from patients with Morgellons disease. Clin Cosmet Investig Dermatol. 2013; 6:1-21. doi: 10.2147/ccid.S39017

[41] Savely VR, Leitao MM, Stricker RB. The mystery of Morgellons disease: Infection or delusion? Am J Clin Dermatol. 2006; 7(1):1-5. doi: 10.2165/00128071-200607010-00001

[42] Beuerlein KG, Balogh EA, Feldman SR. Morgellons disease etiology and therapeutic approach: A systematic review. Dermatol Online J. 2021; 27(8). doi: 10.5070/d327854682

[43] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision. United States: American Psychiatric Association.

[44] Lynch PJ. Delusions of parasitosis. Semin Dermatol. 1993; 12(1):39-45.

[45] Dewan P, Miller J, Musters C, Taylor RE, Bewley AP. Delusional infestation with unusual pathogens: A report of three cases. Clin Exp Dermatol. 2011; 36(7):745-748. doi: 10.1111/j.1365-2230.2011.04086.x

[46] Caputo V, Bonoldi E, Citterio A, Rongioletti F. The challenge of Morgellons disease: A patient with clinicopathologic correlation. Clin Dermatol. 2022; 40(6):686-690. doi: 10.1016/j.clindermatol.2022.07.003

[47] Joseph SM, Siddiqui W. Delusional disorder. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023.

[48] Hammers-Berggren S, Lebech AM, Karlsson M, Svenungsson B, Hansen K, Stiernstedt G. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. J Clin Microbiol. 1994; 32(6):1519-1525. doi: 10.1128/jcm.32.6.1519-1525.1994

[49] Savely VR, Stricker RB. Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology. Clin Cosmet Investig Dermatol. 2010; 3:67-78. doi: 10.2147/ccid.s9520

[50] Rare Genomics Institute. Morgellons. Rare Genomics Institute. Available from: https://www.raregenomics.org/morgellons [Last accessed 2024 Nov 21].

[51] Reddit. My Mom Says She Has Morgellons, How Can I Help? Can I Help? Reddit. Available from: https://www.reddit.com/r/askdocs/comments/18layrn/my_mom_says_she_ has_morgellons_how_can_i_help_can [Last accessed 2024 Nov 21].

[52] Reddit. Morgellons Disease Cause of Untreated Lyme? Reddit. Available from: https://www.reddit.com/r/lyme/comments/v8o6wp/morgellons_disease_cause_of_untreated_lyme [Last accessed 2024 Nov 21].

[53] Bartholomew RE, Wessely S, Rubin GJ. Mass psychogenic illness and the social network: Is it changing the pattern of outbreaks? J R Soc Med. 2012; 105(12):509-512. doi: 10.1258/jrsm.2012.120053

[54] The Morgellons Research Foundation. Morgellons Disease. The Morgellons Research Foundation (MRF). Available from: https://www.morgellons.org [Last accessed 2024 Nov 21].

[55] Ferreira BR, Roccia MG, Cardoso JC, et al. History of Morgellons disease: The same name for different psychodermatologic diseases? Wien Med Wochenschr. 2017; 167(Suppl 1):49-51. doi: 10.1007/s10354-017-0552-8

[56] Mindru FM, Radu AF, Bumbu AG, Radu A, Bungau SG. Insights into the medical evaluation of ekbom syndrome: An overview. Int J Mol Sci. 2024; 25(4):2151. doi: 10.3390/ijms25042151

[57] Yan BY, Jorizzo JL. Management of Morgellons disease with low-dose trifluoperazine. JAMA Dermatol. 2018; 154(2):216-218. doi: 10.1001/jamadermatol.2017.5175

[58] Dowben JS, Kowalski PC, Keltner NL. Formication, tactile hallucinations, delusional parasitosis, and Morgellons: Enough to make your skin crawl. Perspect Psychiatr Care. 2017; 53(4):220-221. doi: 10.1111/ppc.12246

[59] World Health Organization.International Classification of Diseases, 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization; 1990.

[60] Soares-Weiser K, Maayan N, Bergman H, et al. First rank symptoms for schizophrenia. Cochrane Database Syst Rev. 2015; 1(1):Cd010653. doi: 10.1002/14651858.CD010653.pub2

[61] Rhoades RB, Leifer KN, Cohan R, Wittig HJ. Suppression of histamine-induced pruritus by three antihistaminic drugs. J Allergy Clin Immunol. 1975; 55(3):180-185. doi: 10.1016/0091-6749(75)90014-7

[62] Chandran V, Kurien G. Dermatitis artefacta. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2022.

[63] Psychodermatology UK. Habit Reversal. Psychodermatology UK. Available from: https://www.psychodermatology.co.uk/habit-reversal [Last accessed 2024 Nov 21].

[64] Reid EE, Lio PA. Successful treatment of Morgellons disease with pimozide therapy. Arch Dermatol. 2010; 146(10):1191-1193. doi: 10.1001/archdermatol.2010.276

[65] National Research Council Committee on AFfDaNToD. The National Academies Collection:Reports funded by National Institutes of Health. In: Toward Precision Medicine: Building A Knowledge Network for Biomedical Research and A New Taxonomy of Disease. United States: National Academies Press (US), National Academy of Sciences; 2011.

[66] Desbordes G, Li A, Loggia ML, et al. Evoked itch perception is associated with changes in functional brain connectivity. Neuroimage Clin. 2015; 7:213-221. doi: 10.1016/j.nicl.2014.12.002

[67] Kemperman P, Bruijn TVM, Vulink NCC, Mulder MMC. Drug-induced delusional infestation. Acta Derm Venereol. 2022;102:adv00663. doi: 10.2340/actadv.v102.183

[68] Sönmez D, Hocaoglu C. Morgellon’s disease due to methamphetamine use: A case report. Psychiatry Behav Sci. 2023; 13:114-116. doi: 10.5455/PBS.20220714030333

[69] Piipponen M, Li D, Xu Landén N. The immune functions of keratinocytes in skin wound healing. Int J Mol Sci. 2020;21:E8790. doi: 10.3390/ijms21228790

[70] Chhabra L, Sareen P, Trivedi N. The silver man: A rare cosmetic complication of alternative medicine. BMJ Case Rep. 2013;2013:bcr2013009728. doi: 10.1136/bcr-2013-009728

[71] Conroy D. Morgellon’s Syndrome: Evidence of a Microorganism Causing An Unexplained Dermopath. 1st ed. United States: CRC Press; 2010.

[72] American Psychiatric Association. Stigma, Prejudice and Discrimination against People with Mental Illness. American Psychiatric Association. Available from: https://www.psychiatry.org/patients-families/stigma-and-discrimination [Last accessed 2024 Nov 21].

[73] Mayne PJ. Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis, and ehrlichiosis in an Australian cohort. Int J Gen Med. 2015; 8:15-26. doi: 10.2147/ijgm.S75825

[74] Psychodermatology UK. Royal London Hospital. Psychodermatology UK. Available from: https://www.psychodermatology.co.uk/royal-london [Last accessed 2024 Nov 21].

[75] Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994; 19(3):210-216. doi: 10.1111/j.1365-2230.1994.tb01167.